As of 2025-07-08, the Relative Valuation of Landos Biopharma Inc (LABP) is (131.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -674.4%.
The range of the Relative Valuation is (121.21) - (136.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 17.3x | 14.4x |
| Forward P/E multiples | 15.3x - 21.8x | 18.8x |
| Fair Price | (121.21) - (136.73) | (131.70) |
| Upside | -628.6% - -696.3% | -674.4% |
| Date | P/E |